Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/4841
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMendes, Felipe Lacerda-
dc.contributor.authorCavalcante, Tânia Maria-
dc.contributor.authorViegas, João Ricardo-
dc.contributor.authorSzklo, Andre Salem-
dc.date.accessioned2022-01-07T19:56:51Z-
dc.date.available2022-01-07T19:56:51Z-
dc.date.issued2020-
dc.identifier.citationSalem Szklo A, Lacerda Mendes F, Cavalcante TM, Viegas JR. Interferência da Indústria do Tabaco no Brasil: a Necessidade do Ajuste de Contas. Rev. Bras. Cancerol. [Internet]. 28º de maio de 2020 [citado 7º de janeiro de 2022];66(2):e-11878. Disponível em: https://rbc.inca.gov.br/revista/index.php/revista/article/view/878pt_BR
dc.identifier.issn2176-9745-
dc.identifier.otherDOI: https://doi.org/10.32635/2176-9745.RBC.2020v66n2.878-
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/4841-
dc.description.abstractIntroduction: In Brazil, illegal actions of advertising, promotion, and sponsorship by part of the tobacco industry are increasingly identified in music events, and through social media, aimed mainly to attract young people to use cigarettes. Objective: To develop a methodology that allows the creation of a parameter of quantification of the negative impacts to the health sector of non-compliance with the law. Method: Combination of the current national information about i) the equivalence between “mean direct cost of medical care” and “deaths by diseases attributable to tobacco addiction” and ii) the equivalence between “the portion of the profit translated into marketing actions” and “deaths of smokers who contributed for the generation of this profit through purchase of cigarettes” in order to obtain the relation between “direct cost of the treatment” vs “portion of the profit translated into market actions”. The diseases selected were those that presented the biggest direct cost of treatment attributable to tobacco. Results: For every cent invested in marketing strategies by the tobacco industry, Brazil spends 1.93 times more financial resources to treat tobacco-related diseases. Conclusion: The measurement of the liability for non-compliance of the tobacco national legislation is essential to offset part of the associated costs of the treatment of patients and programs of tobacco cessation to favor the reduction of smoking prevalence in Brazil.pt_BR
dc.language.isoenpt_BR
dc.publisherRevista Brasileira de Cancerologiapt_BR
dc.subjectIndústria do Tabacopt_BR
dc.subjectTobacco Industrypt_BR
dc.subjectPublicidade de Produtos Derivados do Tabacopt_BR
dc.subjectTobacco-Derived Products Publicitypt_BR
dc.subjectTabagismo/economiapt_BR
dc.subjectTobacco Use Disorder/economicspt_BR
dc.subjectCompensação e Reparaçãopt_BR
dc.subjectCompensation and Redresspt_BR
dc.subjectMarketing Socialpt_BR
dc.subjectSocial Marketingpt_BR
dc.titleInterferência da Indústria do Tabaco no Brasil: A Necessidade do Ajuste de Contaspt_BR
dc.title.alternativeTobacco Industry Interference in Brazil: the Necessity of Settling Accountspt_BR
dc.title.alternativeInterferencia de la Industria Tabacalera en Brasil: la Necesidad del Ajuste de Cuentaspt_BR
dc.TypeArticlept_BR
Appears in Collections:Artigos de Periódicos da área de Pesquisa Populacional

Files in This Item:
File Description SizeFormat 
sfreire,+art11-ingles.pdf660.86 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.